Solute carrier transporters: potential targets for digestive system neoplasms

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• LiZSLiQThe latest 2010 WHO classification of tumors of digestive systemZhonghua Bing Li Xue Za Zhi2011405351354 Chinese21756837
   PubMedGoogle Scholar
• FuMZouCPanLLong noncoding RNAs in digestive system cancers: functional roles, molecular mechanisms, and clinical implications (review)Oncol Rep20163631207121827431376
   PubMed Web of Science ®Google Scholar
• MarusykAPolyakKTumor heterogeneity: causes and consequencesBiochim Biophys Acta20101805110511719931353
   PubMed Web of Science ®Google Scholar
• YangNJHinnerMJGetting across the cell membrane: an overview for small molecules, peptides, and proteinsMethods Mol Biol20151266295325560066
   PubMedGoogle Scholar
• International Transporter ConsortiumGiacominiKMHuangSMMembrane transporters in drug developmentNat Rev Drug Discov20109321523620190787
   PubMed Web of Science ®Google Scholar
• SinghHVelamakanniSDeeryMJHowardJWeiSLvan VeenHWATP-dependent substrate transport by the ABC transporter MsbA is proton-coupledNat Commun201671238727499013
   PubMed Web of Science ®Google Scholar
• HeLVasiliouKNebertDWAnalysis and update of the human solute carrier (SLC) gene superfamilyHum Genom200932195206
   PubMedGoogle Scholar
• LiQShuYRole of solute carriers in response to anticancer drugsMol Cell Ther201421526056583
   PubMedGoogle Scholar
• DiallinasGUnderstanding transporter specificity and the discrete appearance of channel-like gating domains in transportersFront Pharmacol2014520725309439
   PubMed Web of Science ®Google Scholar
• ColasCUngPMSchlessingerASLC transporters: structure, function, and drug discoveryMedchemcomm2016761069108127672436
   PubMed Web of Science ®Google Scholar
• NigamSKWhat do drug transporters really do?Nat Rev Drug Discov2015141294425475361
   PubMed Web of Science ®Google Scholar
• LiYLuJPaxtonJWThe role of ABC and SLC transporters in the pharmacokinetics of dietary and herbal phytochemicals and their interactions with xenobioticsCurr Drug Metab201213562463922475331
   PubMed Web of Science ®Google Scholar
• GulecSAndersonGJCollinsJFMechanistic and regulatory aspects of intestinal iron absorptionAm J Physiol Gastrointest Liver Physiol20143074G397G40924994858
   PubMed Web of Science ®Google Scholar
• ChanKBusqueSMSailerMLoss of function mutation of the Slc38a3 glutamine transporter reveals its critical role for amino acid metabolism in the liver, brain, and kidneyPflugers Arch2016468221322726490457
   PubMed Web of Science ®Google Scholar
• SugaTYamaguchiHSatoTMaekawaMGotoJManoNPreference of conjugated bile acids over unconjugated bile acids as substrates for OATP1B1 and OATP1B3PLoS One2017121e016971928060902
   PubMed Web of Science ®Google Scholar
• SatoTYamaguchiHKogawaTAbeTManoNOrganic anion transporting polypeptides 1B1 and 1B3 play an important role in uremic toxin handling and drug-uremic toxin interactions in the liverJ Pharm Pharm Sci201417447548425579430
   PubMed Web of Science ®Google Scholar
• HolmstromPGafvelsMErikssonLCExpression of iron regulatory genes in a rat model of hepatocellular carcinomaLiver Int200626897698516953838
   PubMed Web of Science ®Google Scholar
• BrookesMJHughesSTurnerFEModulation of iron transport proteins in human colorectal carcinogenesisGut200655101449146016641131
   PubMed Web of Science ®Google Scholar
• BoultJRobertsKBrookesMJOverexpression of cellular iron import proteins is associated with malignant progression of esophageal adenocarcinomaClin Cancer Res200814237938718223212
   PubMed Web of Science ®Google Scholar
• YounPKimSAhnJHKimYParkJDRyuDYRegulation of iron metabolism-related genes in diethylnitrosamine-induced mouse liver tumorsToxicol Lett2009184315115819061943
   PubMed Web of Science ®Google Scholar
• XueXTaylorMAndersonEHypoxia-inducible factor-2alpha activation promotes colorectal cancer progression by dysregulating iron homeostasisCancer Res20127292285229322419665
   PubMed Web of Science ®Google Scholar
• RadulescuSBrookesMJSalgueiroPLuminal iron levels govern intestinal tumorigenesis after Apc loss in vivoCell Rep20122227028222884366
   PubMed Web of Science ®Google Scholar
• ChuaACKlopcicBRHoDSDietary iron enhances colonic inflammation and IL-6/IL-11-Stat3 signaling promoting colonic tumor development in micePLoS One2013811e7885024223168
   PubMed Web of Science ®Google Scholar
• XueXRamakrishnanSKWeiszKIron uptake via DMT1 integrates cell cycle with JAK-STAT3 signaling to promote colorectal tumorigenesisCell Metab201624344746127546461
   PubMed Web of Science ®Google Scholar
• LiZLaiZYaKCorrelation between the expression of divalent metal transporter 1 and the content of hypoxia-inducible factor-1 in hypoxic HepG2 cellsJ Cell Mol Med200812256957918419598
   PubMed Web of Science ®Google Scholar
• LianJJingYDongQmiR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinomaOncotarget2016732672268326684241
   PubMedGoogle Scholar
• ChengXWeiLHuangXSolute carrier family 39 member 6 gene promotes aggressiveness of esophageal carcinoma cells by increasing intracellular levels of zinc, activating phosphatidylinositol 3-kinase signaling, and up-regulating genes that regulate metastasisGastroenterology2017152819851997.e1228209530
   PubMed Web of Science ®Google Scholar
• KuboshimaMShimadaHLiuTLIdentification of a novel SEREX antigen, SLC2A1/GLUT1, in esophageal squamous cell carcinomaInt J Oncol200628246346816391802
   PubMed Web of Science ®Google Scholar
• TengCFHsiehWCWuHCHepatitis B virus pre-S2 mutant induces aerobic glycolysis through mammalian target of rapamycin signal cascadePLoS One2015104e012237325909713
   PubMed Web of Science ®Google Scholar
• YanSWangYChenMLiGFanJDeregulated SLC2A1 promotes tumor cell proliferation and metastasis in gastric cancerInt J Mol Sci2015167161441615726193257
   PubMed Web of Science ®Google Scholar
• UenoMToyotaMAkinoKAberrant methylation and histone deacetylation associated with silencing of SLC5A8 in gastric cancerTumour Biol200425313414015361710
   PubMedGoogle Scholar
• ParkJYHelmJFZhengWSilencing of the candidate tumor suppressor gene solute carrier family 5 member 8 (SLC5A8) in human pancreatic cancerPancreas2008364e32e3918437076
   PubMed Web of Science ®Google Scholar
• GuravASivaprakasamSBhutiaYDBoettgerTSinghNGanapathyVSlc5a8, a Na+-coupled high-affinity transporter for short-chain fatty acids, is a conditional tumour suppressor in colon that protects against colitis and colon cancer under low-fibre dietary conditionsBiochem J2015469226727825984582
   PubMedGoogle Scholar
• ZhangYBaoYLYangMTActivin A induces SLC5A8 expression through the Smad3 signaling pathway in human colon cancer RKO cellsInt J Biochem Cell Biol201042121964197220732443
   PubMed Web of Science ®Google Scholar
• PalanisamyNAteeqBKalyana-SundaramSRearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanomaNat Med201016779379820526349
   PubMed Web of Science ®Google Scholar
• HeiseMLautemAKnapsteinJDownregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significanceBMC Cancer20121210922439694
   PubMed Web of Science ®Google Scholar
• ZhuLDuMGuDGenetic variant rs7758229 in 6q26-q27 is not associated with colorectal cancer risk in a Chinese populationPLoS One201383e5925623555006
   PubMed Web of Science ®Google Scholar
• LautemAHeiseMGraselADownregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinomaInt J Oncol20134241297130423440379
   PubMed Web of Science ®Google Scholar
• Mohelnikova-DuchonovaBBrynychovaVHlavacVThe association between the expression of solute carrier transporters and the prognosis of pancreatic cancerCancer Chemother Pharmacol201372366968223934321
   PubMed Web of Science ®Google Scholar
• JungYJunYLeeHYCharacterization of SLC22A18 as a tumor suppressor and novel biomarker in colorectal cancerOncotarget2015628253682538026196590
   PubMedGoogle Scholar
• KitadaNTakaraKMinegakiTFactors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell linesCancer Chemother Pharmacol200862457758418030470
   PubMed Web of Science ®Google Scholar
• LinRLiXLiJLong-term cisplatin exposure promotes methylation of the OCT1 gene in human esophageal cancer cellsDig Dis Sci201358369469823053895
   PubMed Web of Science ®Google Scholar
• Le RoyBTixierLPereiraBAssessment of the relation between the expression of oxaliplatin transporters in colorectal cancer and response to FOLFOX-4 adjuvant chemotherapy: a case control studyPLoS One2016112e014873926859833
   PubMed Web of Science ®Google Scholar
• YokooSMasudaSYonezawaATeradaTKatsuraTInuiKSignificance of organic cation transporter 3 (SLC22A3) expression for the cytotoxic effect of oxaliplatin in colorectal cancerDrug Metab Dispos200836112299230618710896
   PubMed Web of Science ®Google Scholar
• QuQQuJGuoYZhouBTZhouHHLuteolin potentiates the sensitivity of colorectal cancer cell lines to oxaliplatin through the PPARgamma/OCTN2 pathwayAnticancer Drugs20142591016102725075794
   PubMed Web of Science ®Google Scholar
• ShimakataTKamoshidaSKawamuraJImmunohisto-chemical expression profiles of solute carrier transporters in alpha-fetoprotein-producing gastric cancerHistopathology201669581282127245475
   PubMed Web of Science ®Google Scholar
• MattieMRaitanoAMorrisonKThe discovery and preclinical development of ASG-5ME, an antibody-drug conjugate targeting SLC44A4-positive epithelial tumors including pancreatic and prostate cancerMol Cancer Ther201615112679268727550944
   PubMed Web of Science ®Google Scholar
• ZhuXLiangJShrubsoleMJCalcium intake and ion transporter genetic polymorphisms interact in human colorectal neoplasia risk in a 2-phase studyJ Nutr2014144111734174125165391
   PubMed Web of Science ®Google Scholar
• SchliessFSchaferCvom DahlSFischerRLordnejadMRHaussingerDExpression and regulation of the Na(+)/K(+)/2Cl(–) cotransporter NKCC1 in rat liver and human HuH-7 hepatoma cellsArchBiochem Biophys20024012187197
   PubMed Web of Science ®Google Scholar
• ZhangYLiuYYeYQuantitative proteome analysis of colorectal cancer-related differential proteinsJ Cancer Res Clin Oncol2017143223324127659785
   PubMed Web of Science ®Google Scholar
• ShiozakiANakoYIchikawaDRole of the Na (+)/K (+)/2Cl(−) cotransporter NKCC1 in cell cycle progression in human esophageal squamous cell carcinomaWorld J Gastroenterol201420226844685924944475
   PubMed Web of Science ®Google Scholar
• XuLLiXCaiMIncreased expression of solute carrier family 12 member 5 via gene amplification contributes to tumour progression and metastasis and associates with poor survival in colorectal cancerGut201665463564625947013
   PubMed Web of Science ®Google Scholar
• LauriolaMUgoliniGRosatiGIdentification by a Digital Gene Expression Displayer (DGED) and test by RT-PCR analysis of new mRNA candidate markers for colorectal cancer in peripheral bloodInt J Oncol201037251952520596680
   PubMed Web of Science ®Google Scholar
• OstasiewiczBOstasiewiczPDus-SzachniewiczKOstasiewiczKZiolkowskiPQuantitative analysis of gene expression in fixed colorectal carcinoma samples as a method for biomarker validationMol Med Rep20161365084509227121919
   PubMed Web of Science ®Google Scholar
• PitulePVycitalOBruhaJDifferential expression and prognostic role of selected genes in colorectal cancer patientsAnticancer Res201333114855486524222123
   PubMed Web of Science ®Google Scholar
• LeeJLeeSEKangSYIdentification of ROS1 rearrangement in gastric adenocarcinomaCancer201311991627163523400546
   PubMed Web of Science ®Google Scholar
• ZhangJXXuYGaoYDecreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathwayMol Cancer20171611828114937
   PubMed Web of Science ®Google Scholar
• LiYChenXLuHKnockdown of SLC34A2 inhibits hepatocellular carcinoma cell proliferation and invasionOncol Res201624651151928281971
   PubMed Web of Science ®Google Scholar
• MugurumaMUnamiAKankiMPossible involvement of oxidative stress in piperonyl butoxide induced hepatocarcinogenesis in ratsToxicology20072361–2617517498859
   PubMed Web of Science ®Google Scholar
• ParkYYSohnBHJohnsonRLYes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinomaHepatology201663115917226389641
   PubMed Web of Science ®Google Scholar
• ChangEYChangYCShunCTInhibition of prostaglandin reductase 2, a putative oncogene overexpressed in human pancreatic adenocarcinoma, induces oxidative stress-mediated cell death involving xCT and CTH gene expressions through 15-keto-GE2PLoS One2016111e014739026820738
   PubMed Web of Science ®Google Scholar
• KishikawaTOtsukaMTanPSDecreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginineOncotarget20156108339835225826076
   PubMedGoogle Scholar
• ChenCFHsuECLinKTOverlapping high-resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinomaHepatology20105251690170120799341
   PubMed Web of Science ®Google Scholar
• KinoshitaMMiyataMUnderexpression of mRNA in human hepatocellular carcinoma focusing on eight lociHepatology200236243343812143053
   PubMed Web of Science ®Google Scholar
• CuiYKonigJNiesATDetection of the human organic anion transporters SLC21A6 (OATP2) and SLC21A8 (OATP8) in liver and hepatocellular carcinomaLab Invest200383452753812695556
   PubMed Web of Science ®Google Scholar
• VavrickaSRJungDFriedMGrutznerUMeierPJKullak-UblickGAThe human organic anion transporting polypeptide 8 (SLCO1B3) gene is transcriptionally repressed by hepatocyte nuclear factor 3beta in hepatocellular carcinomaJ Hepatol200440221221814739090
   PubMed Web of Science ®Google Scholar
• Vander BorghtSLibbrechtLBlokzijlHDiagnostic and pathogenetic implications of the expression of hepatic transporters in focal lesions occurring in normal liverJ Pathol2005207447148216161006
   PubMed Web of Science ®Google Scholar
• VasuriFGolfieriRFiorentinoMOATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantationVirchows Arch2011459214114621691816
   PubMed Web of Science ®Google Scholar
• TeftWAWelchSLenehanJOATP1B1 and tumour OATP1B3 modulate exposure, toxicity, and survival after irinotecan-based chemotherapyBr J Cancer2015112585786525611302
   PubMed Web of Science ®Google Scholar
• JungDKullak-UblickGAHepatocyte nuclear factor 1 alpha: a key mediator of the effect of bile acids on gene expressionHepatology200337362263112601360
   PubMed Web of Science ®Google Scholar
• RhodesKEZhangWYangDABCB1, SLCO1B1 and UGT1A1 gene polymorphisms are associated with toxicity in metastatic colorectal cancer patients treated with first-line irinotecanDrug Metab Lett200711233019356014
   PubMedGoogle Scholar
• InnocentiFKroetzDLSchuetzEComprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokineticsJ Clin Oncol200927162604261419349540
   PubMed Web of Science ®Google Scholar
• HuangLZhangTXieCSLCO1B1 and SLC19A1 gene variants and irinotecan-induced rapid response and survival: a prospective multicenter pharmacogenetics study of metastatic colorectal cancerPLoS One2013810e7722324143213
   PubMed Web of Science ®Google Scholar
• KounnisVChondrogiannisGMantzarisMDMicrocystin LR shows cytotoxic activity against pancreatic cancer cells expressing the membrane OATP1B1 and OATP1B3 transportersAnticancer Res201535115857586526504008
   PubMed Web of Science ®Google Scholar
• LiuXLamEKWangXPromoter hypermethylation mediates downregulation of thiamine receptor SLC19A3 in gastric cancerTumour Biol2009305–624224819816091
   PubMed Web of Science ®Google Scholar
• NgEKLeungCPShinVYQuantitative analysis and diagnostic significance of methylated SLC19A3 DNA in the plasma of breast and gastric cancer patientsPLoS One201167e2223321789241
   PubMed Web of Science ®Google Scholar
• IkehataMUedaKIwakawaSDifferent involvement of DNA methylation and histone deacetylation in the expression of solute-carrier transporters in 4 colon cancer cell linesBiol Pharm Bull201235330130722382314
   PubMed Web of Science ®Google Scholar
• FigueiredoJCLevineAJLeeWHGenes involved with folate uptake and distribution and their association with colorectal cancer riskCancer Causes Control201021459760820037791
   PubMed Web of Science ®Google Scholar
• ChenJSChenKTFanCWComparison of membrane fraction proteomic profiles of normal and cancerous human colorectal tissues with gel-assisted digestion and iTRAQ labeling mass spectrometryFEBS J2010277143028303820546304
   PubMed Web of Science ®Google Scholar
• WongCCQianYLiXSLC25A22 promotes proliferation and survival of colorectal cancer cells with KRAS mutations and xenograft tumor progression in mice via intracellular synthesis of aspartateGastroenterology20161515945960.e94627451147
   PubMed Web of Science ®Google Scholar
• TangZLiCKangBGaoGLiCZhangZGEPIA: a web server for cancer and normal gene expression profiling and interactive analysesNucleic Acids Res Epub2017412
   Web of Science ®Google Scholar
• JeongJEideDJThe SLC39 family of zinc transportersMol Aspects Med2013342–361261923506894
   PubMed Web of Science ®Google Scholar
• EideDJZinc transporters and the cellular trafficking of zincBiochim Biophys Acta20061763771172216675045
   PubMed Web of Science ®Google Scholar
• PrasadASBeckFWSnellDCKucukOZinc in cancer preventionNutr Cancer200961687988720155630
   PubMed Web of Science ®Google Scholar
• MarshallKMLavalMEstacioOActivation by zinc of the human gastrin gene promoter in colon cancer cells in vitro and in vivoMetallomics20157101390139826404630
   PubMed Web of Science ®Google Scholar
• HesselsAMTaylorKMMerkxMMonitoring cytosolic and ER Zn(2+) in stimulated breast cancer cells using genetically encoded FRET sensorsMetallomics20168221121726739447
   PubMed Web of Science ®Google Scholar
• TaylorKMVichovaPJordanNHiscoxSHendleyRNicholsonRIZIP7-mediated intracellular zinc transport contributes to aberrant growth factor signaling in antihormone-resistant breast cancer cellsEndocrinology2008149104912492018583420
   PubMed Web of Science ®Google Scholar
• CohenLAzriel-TamirHArotskerNSeklerIHershfinkelMZinc sensing receptor signaling, mediated by GPR39, reduces butyrate-induced cell death in HT29 colonocytes via upregulation of clusterinPLoS One201274e3548222545109
   PubMed Web of Science ®Google Scholar
• RudolfERudolfKLow zinc environment induces stress signaling, senescence and mixed cell death modalities in colon cancer cellsApoptosis201520121651166526446979
   PubMed Web of Science ®Google Scholar
• ChandlerPKochupurakkalBSAlamSRichardsonALSoybelDIKelleherSLSubtype-specific accumulation of intracellular zinc pools is associated with the malignant phenotype in breast cancerMol Cancer201615226728511
   PubMed Web of Science ®Google Scholar
• KagaraNTanakaNNoguchiSHiranoTZinc and its transporter ZIP10 are involved in invasive behavior of breast cancer cellsCancer Sci200798569269717359283
   PubMed Web of Science ®Google Scholar
• Takatani-NakaseTMigration behavior of breast cancer cells in the environment of high glucose level and the role of zinc and its transporterYakugaku Zasshi2013133111195119924189560
   PubMed Web of Science ®Google Scholar
• CuiXZhangYYangJZIP4 confers resistance to zinc deficiency-induced apoptosis in pancreatic cancerCell Cycle20141371180118624553114
   PubMed Web of Science ®Google Scholar
• MiyaiTHojyoSIkawaTZinc transporter SLC39A10/ZIP10 facilitates antiapoptotic signaling during early B-cell developmentProc Natl Acad Sci USA201411132117801178525074913
   PubMed Web of Science ®Google Scholar
• KomoriJMarusawaHMachimotoTActivation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinomaHepatology200847388889618306229
   PubMed Web of Science ®Google Scholar
• KoepsellHEndouHThe SLC22 drug transporter familyPflugers Arch2004447566667612883891
   PubMed Web of Science ®Google Scholar
• BoyerJLBile formation and secretionCompr Physiol2013331035107823897680
   PubMed Web of Science ®Google Scholar
• Kullak-UblickGABeuersUPaumgartnerGHepatobiliary transportJ Hepatol2000321 Suppl31810728790
   PubMedGoogle Scholar
• NyquistMDPrasadBMostaghelEAHarnessing solute carrier transporters for precision oncologyMolecules2017224 pii:E539
   PubMed Web of Science ®Google Scholar
• HuGHenkeAKarpowiczRJJrNew fluorescent substrate enables quantitative and high-throughput examination of vesicular monoamine transporter 2 (VMAT2)ACS Chem Biol2013891947195423859623
   PubMed Web of Science ®Google Scholar
• UlanovskayaOACuiJKronSJKozminSAA pairwise chemical genetic screen identifies new inhibitors of glucose transportChem Biol201118222223021338919
   PubMedGoogle Scholar
• LinLYeeSWKimRBGiacominiKMSLC transporters as therapeutic targets: emerging opportunitiesNat Rev Drug Discov201514854356026111766
   PubMed Web of Science ®Google Scholar
• AndrianopoulosGDNelsonRLBarchDHNyhusLMSulfasalazine alters the character of dimethylhydrazine-induced colorectal carcinoma in ratsAnticancer Res198996172517282576350
   PubMed Web of Science ®Google Scholar
• SuzukiSSakamotoSMitamuraTSassaSKudoHYamashitaYPreventive effects of sulphasalazine on colorectal carcinogenesis in mice with ulcerative colitisIn Vivo200014346346610904883
   PubMed Web of Science ®Google Scholar
• MaMZChenGWangPXc- inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanismCancer Lett20153681889626254540
   PubMed Web of Science ®Google Scholar
• HuangZGuoKJGuoRXHeSGEffects of 5-fluouracil combined with sulfasalazine on human pancreatic carcinoma cell line BxPC-3 proliferation and apoptosis in vitroHepatobiliary Pancreat Dis Int20076331232017548258
   PubMed Web of Science ®Google Scholar
• MuerkosterSArltAWittMUsage of the NF-kappaB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancerInt J Cancer2003104446947612584745
   PubMed Web of Science ®Google Scholar
• TanakaTNishikawaAShimaHInhibitory effects of chlorogenic acid, reserpine, polyprenoic acid (E-5166), or coffee on hepatocarcinogenesis in rats and hamstersBasic Life Sci1990524294402327945
   PubMedGoogle Scholar
• DunnickJKEustisSLDecreases in spontaneous tumors in rats and mice after treatment with amphetamineToxicology19916733253322048132
   PubMed Web of Science ®Google Scholar
• SugieSTanakaTKuniyasuTMoriHInhibitory effect of reserpine on N-2-fluorenylacetamide-induced hepatocarcinogenesis in ratsToxicol Lett19873721151193603587
   PubMed Web of Science ®Google Scholar
• De MiglioMRMuroniMRSimileMMImplication of Bcl-2 family genes in basal and D-amphetamine-induced apoptosis in preneoplastic and neoplastic rat liver lesionsHepatology200031495696510733553
   PubMed Web of Science ®Google Scholar
• van RooijenNKorsNter HartHClaassenEIn vitro and in vivo elimination of macrophage tumor cells using liposome-encapsulated dichloromethylene diphosphonateVirchows Arch B Cell Pathol Incl Mol Pathol19885442412452895535
   PubMedGoogle Scholar
• GriesmannHDrexelCMilosevicNPharmacological macrophage inhibition decreases metastasis formation in a genetic model of pancreatic cancerGut20176671278128527013602
   PubMed Web of Science ®Google Scholar
• KruseJvon BernstorffWEvertKMacrophages promote tumour growth and liver metastasis in an orthotopic syngeneic mouse model of colon cancerInt J Colorectal Dis201328101337134923657400
   PubMed Web of Science ®Google Scholar
• ZhangWZhuXDSunHCDepletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effectsClin Cancer Res201016133420343020570927
   PubMed Web of Science ®Google Scholar
• Gil-AdIZolokovALomnitskiLEvaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted miceInt J Oncol200833227728618636148
   PubMed Web of Science ®Google Scholar
• KannenVMariniTTurattiAFluoxetine induces preventive and complex effects against colon cancer development in epithelial and stromal areas in ratsToxicol Lett20112042–313414021554931
   PubMed Web of Science ®Google Scholar
• KannenVHintzscheHZanetteDLAntiproliferative effects of fluoxetine on colon cancer cells and in a colonic carcinogen mouse modelPLoS One2012711e5004323209640
   PubMed Web of Science ®Google Scholar
• KannenVGarciaSBSilvaWAJrOncostatic effects of fluoxetine in experimental colon cancer modelsCell Signal20152791781178826004136
   PubMed Web of Science ®Google Scholar
• KuwaharaJYamadaTEgashiraNComparison of the anti-tumor effects of selective serotonin reuptake inhibitors as well as serotonin and norepinephrine reuptake inhibitors in human hepatocellular carcinoma cellsBiol Pharm Bull20153891410141426328498
   PubMed Web of Science ®Google Scholar
• MunARLeeSJKimGBKangHSKimJSKimSJFluoxetine-induced apoptosis in hepatocellular carcinoma cellsAnticancer Res20133393691369724023297
   PubMed Web of Science ®Google Scholar
• ShiozakiAMiyazakiHNiisatoNFurosemide, a blocker of Na+/K+/2Cl− cotransporter, diminishes proliferation of poorly differentiated human gastric cancer cells by affecting G0/G1 stateJ Physiol Sci200656640140617052386
   PubMed Web of Science ®Google Scholar
• MalamasASJinEZhangQHaagaJLuZRAnti-angiogenic effects of bumetanide revealed by DCE-MRI with a biodegradable macromolecular contrast agent in a colon cancer modelPharm Res20153293029304325840948
   PubMed Web of Science ®Google Scholar
• SeolHSLeeSESongJSGlutamate release inhibitor, riluzole, inhibited proliferation of human hepatocellular carcinoma cells by elevated ROS productionCancer Lett2016382215716527612558
   PubMed Web of Science ®Google Scholar